DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Psoriasis
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
- George Jeha, MD
- Deborah Hilton, MD
- Maria Bao-Loc-Trung, BS
In The Pipeline: Phase 1, 2, and 3
In The Pipeline: Phase 1, 2, and 3
Psoriasis
In The Pipeline: Phase 1, 2, and 3
IFPA World PsO and PsA Conference
IFPA World PsO and PsA Conference
Psoriasis
IFPA World PsO and PsA Conference
- Wilson Liao, MD
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
Psoriasis
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
- Jashin J. Wu, MD, FAAD
- Alexander Egeberg
- Priya Vedula Engel, MPH
- Sogol S. Javadi, BS
- Michael Korin
- Brandon Smith, BA